Effectiveness of early budesonide intervention in Caucasian versus Asian patients with asthma: 3‐year results of the START study

Objective and background:  Few studies have assessed the effectiveness of inhaled corticosteroid therapy exclusively in Asian patients with asthma. The present analysis compared the efficacy of early intervention with inhaled budesonide in Caucasian and Asian patients over the first 3 years of the inhaled Steroid Treatment As Regular Therapy in early asthma study.

[1]  H. Bisgaard,et al.  Understanding mild persistent asthma in children: the next frontier. , 2005, The Journal of allergy and clinical immunology.

[2]  I. Hall.  Pharmacogenetics and ethnicity: more complexities of personalized prescribing. , 2005, American journal of respiratory and critical care medicine.

[3]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[4]  A Pietinalho,et al.  Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study. , 2004, Respiratory medicine.

[5]  R. Pauwels,et al.  Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. , 2003, The Journal of allergy and clinical immunology.

[6]  G. Fritz,et al.  Medication adherence in pediatric asthma: reasoning, responsibility, and behavior. , 2003, Journal of pediatric psychology.

[7]  William W Busse,et al.  Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial , 2003, The Lancet.

[8]  N. Zhong,et al.  Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. , 2003, The Journal of allergy and clinical immunology.

[9]  C. Wold,et al.  Prevalence of Childhood Asthma and Associated Morbidity in Los Angeles County: Impacts of Race/Ethnicity and Income , 2003, The Journal of asthma : official journal of the Association for the Care of Asthma.

[10]  Paula Lozano,et al.  Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. , 2002, The Journal of allergy and clinical immunology.

[11]  M. Kennedy,et al.  Beta-adrenergic receptor polymorphisms and drug responses in asthma. , 2002, Pharmacogenomics.

[12]  M. Zacharisen,et al.  National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002. , 2002, The Journal of allergy and clinical immunology.

[13]  R. Pauwels,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[14]  R. Pauwels,et al.  The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study: rationale and design. , 2001, Controlled clinical trials.

[15]  V. Paschall.  Long-Term Effects of Budesonide or Nedocromil in Children with Asthma , 2001 .

[16]  T. Miyamoto,et al.  Efficacy of budesonide Turbuhaler® compared with that of beclomethasone dipropionate pMDI in Japanese patients with moderately persistent asthma , 2001, Respirology.

[17]  Scott T. Weiss,et al.  Effect of Polymorphism of the β2-Adrenergic Receptor on Response to Regular Use of Albuterol in Asthma , 2001, International Archives of Allergy and Immunology.

[18]  Helen Brown,et al.  Applied Mixed Models in Medicine , 2000, Technometrics.

[19]  N Franklin Adkinson,et al.  Long-term effects of budesonide or nedocromil in children with asthma. , 2000, The New England journal of medicine.

[20]  J. Drazen,et al.  Asthma exacerbations during long term â agonist use : influence of â 2 adrenoceptor polymorphism , 2000 .

[21]  S. Suissa,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[22]  E. Silverman,et al.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. , 2000, American journal of respiratory and critical care medicine.

[23]  Edersen,et al.  EFFECT OF LONG-TERM TREATMENT WITH INHALED BUDESONIDE ON ADULT HEIGHT IN CHILDREN WITH ASTHMA , 2000 .

[24]  A. Litonjua,et al.  Race, socioeconomic factors, and area of residence are associated with asthma prevalence , 1999, Pediatric pulmonology.

[25]  T. Joos,et al.  Growth in Asthmatic Children Treated with Fluticasone Propionate , 1999 .

[26]  D. Thomason,et al.  Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics , 1999, Clinical pharmacology and therapeutics.

[27]  J. Haines,et al.  Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. , 1999, Pharmacogenetics.

[28]  J Vestbo,et al.  A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.

[29]  R. Nathan,et al.  Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. , 1998, The Journal of pediatrics.

[30]  R. Erickson,et al.  Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. , 1997, The Journal of clinical investigation.

[31]  Brian Lipworth,et al.  Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics , 1997, The Lancet.

[32]  P. Venge,et al.  Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics. , 1997, The European respiratory journal.

[33]  L. Boulet,et al.  Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. , 1995, American journal of respiratory and critical care medicine.

[34]  S. Holgate,et al.  Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. , 1995, American journal of respiratory and critical care medicine.

[35]  T. Haahtela,et al.  Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. , 1994, The New England journal of medicine.

[36]  A. Kamada.  EFFECT OF 22 MONTHS OF TREATMENT WITH INHALED CORTICOSTEROIDS AND/OR BETA-2- AGONISTS ON LUNG FUNCTION, AIRWAY RESPONSIVENESS, AND SYMPTOMS IN CHILDREN WITH ASTHMA , 1994, Pediatrics.

[37]  S. Pedersen,et al.  Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. , 1994, Respiratory medicine.

[38]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[39]  A. Stewart,et al.  Airway wall remodelling in asthma: a novel target for the development of anti-asthma drugs. , 1993, Trends in pharmacological sciences.

[40]  K. Offord,et al.  Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. , 1993, Pediatrics.

[41]  T. Haahtela,et al.  Airway mucosal inflammation even in patients with newly diagnosed asthma. , 1993, The American review of respiratory disease.

[42]  D. Postma,et al.  A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. , 1992, The New England journal of medicine.

[43]  T. Haahtela,et al.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. , 1991, The New England journal of medicine.

[44]  S. Durham,et al.  Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. , 1990, The American review of respiratory disease.

[45]  E. Juniper,et al.  Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. , 1990, The American review of respiratory disease.

[46]  R. Djukanović,et al.  Mucosal inflammation in asthma. , 1990, The American review of respiratory disease.

[47]  T. Lim,et al.  The efficacy of high dose inhaled budesonide in replacing oral corticosteroid in Asian patients with chronic asthma. , 1990, Singapore medical journal.

[48]  G. Borsboom,et al.  Growth of lung and thorax dimensions during the pubertal growth spurt. , 1988, The European respiratory journal.

[49]  A. Woolcock,et al.  Rate of decline of lung function in subjects with asthma. , 1987, European journal of respiratory diseases.

[50]  P. Quanjer,et al.  Changing relationships between stature and lung volumes during puberty. , 1986, Respiration physiology.